Hogan Lovells advises Eurazeo on Qualium Investissement’s continuation fund supporting Proengin

In order to assist Proengin, a world leader in independent Nuclear, Radiological, Biological, and Chemical (NRBC) threat detection technologies, in its next stage of global expansion, Hogan Lovells has provided lead investor Eurazeo with advice on how to structure Qualium Investissement’s first continuation fund.